Stock TMBRQ TREX WIND-DOWN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Trex Wind-down, Inc. Stock

Equities

TMBRQ

US8870802084

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 11:22:21 2024-04-24 am EDT 		5-day change 1st Jan Change
0.0002 USD 0.00% Intraday chart for Trex Wind-down, Inc. 0.00% -83.33%
Apr. 04 First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc. CI
Mar. 20 Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc. CI

Financials (USD)

Sales 2021 887K Sales 2022 83.18K Capitalization 5.2M
Net income 2021 -10M Net income 2022 -19M EV / Sales 2021 11.5 x
Net cash position 2021 14.05M Net cash position 2022 8.75M EV / Sales 2022 -42.7 x
P/E ratio 2021
-1.43 x
P/E ratio 2022
-0.19 x
Employees 9
Yield 2021 *
-
Yield 2022
-
Free-Float 99.37%
More Fundamentals * Assessed data

Chart Trex Wind-down, Inc.

Dynamic Chart

Latest news about Trex Wind-down, Inc.

First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc. CI
Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc. CI
First Motion for Exclusivity Period Extension Filed by Timber Pharmaceuticals, Inc. CI
Timber Pharmaceuticals, Inc. Presents Preliminary Results from the ASCEND Trial in A Late-Breaking Session At the 2024 American Academy of Dermatology Annual Meeting CI
Combined Joint Liquidation Plan & Disclosure Statement Filed by Timber Pharmaceuticals, Inc. CI
Motion for Asset Sale Approved for Timber Pharmaceuticals, Inc. CI
LEO Pharma A/S completed the acquisition of Substantially All the assets from Timber Pharmaceuticals, Inc. (OTCPK:TMBR.Q). CI
Notice of Selection of Winning Bidder & Asset Purchase Agreement Filed for Timber Pharmaceuticals, Inc. CI
Notice for Auction Cancellation Filed by Timber Pharmaceuticals, Inc. CI
Bidding Procedure Approved for Timber Pharmaceuticals, Inc. CI
Final DIP Financing Approved for Timber Pharmaceuticals, Inc. CI
Timber Pharmaceuticals to Be Delisted From NYSE American MT
Timber Pharmaceuticals Receives Court Approval of Motions to Support Business Operations MT
Timber Pharmaceuticals, Inc.(NYSEAM:TMBR) dropped from S&P TMI Index CI
Interim DIP Financing Approved for Timber Pharmaceuticals, Inc. CI
More news

Analyst Recommendations on Trex Wind-down, Inc.

HC Wainwright Downgrades Timber Pharmaceuticals to Neutral From Buy MT
HC Wainwright Adjusts Price Target on Timber Pharmaceuticals to $1 From $1.50, Reiterates Buy Rating MT
HC Wainwright Starts Timber Pharmaceuticals at Buy With $2 Price Target MT
DJ Industrial : Wall Street Sees Mostly Lower Open Ahead of Fed Rate Decision MT
DJ Industrial : Wall Street Futures in Red Territory Ahead of Fed Rate Decision MT
More recommendations

Press releases Trex Wind-down, Inc.

LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals AQ
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market AQ
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American AQ
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance AQ
Timber Pharmaceuticals : Announces NYSE Acceptance of Plan to Regain Listing Compliance - Form 8-K PU
More press releases

Quotes and Performance

1 month+100.00%
3 months-83.33%
6 months-99.99%
Current year-83.33%
More quotes

Highs and lows

1 week
0.00
Extreme 0.0001
0.00
1 month
0.00
Extreme 0.0001
0.00
Current year
0.00
Extreme 0.0001
0.02
1 year
0.00
Extreme 0.0001
3.36
3 years
0.00
Extreme 0.0001
81.50
5 years
0.00
Extreme 0.0001
284.50
10 years
0.00
Extreme 0.0001
284.50
More quotes

Managers and Directors - Trex Wind-down, Inc.

Managers TitleAgeSince
Jessica Bruno-Raiz CTO
 Chief Tech/Sci/R&D Officer - 19-09-30
Members of the board TitleAgeSince
Ed Sitar BRD
 Director/Board Member 63 20-04-30
David Cohen BRD
 Director/Board Member 59 20-08-18
Lubor Gaal BRD
 Director/Board Member 56 20-08-18
More insiders

Quotes

Date Price Change Volume
24-04-24 0.0002 +100.00% 806
24-04-22 0.0001 -50.00% 1,503

Delayed Quote OTC Markets, April 24, 2024 at 11:22 am EDT

More quotes

Company Profile

Trex Wind-Down, Inc., formerly Timber Pharmaceuticals, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code and is winding down its business. The Company has no operation nor generates any revenue.
Sector
Biotechnology & Medical Research
Calendar
2024-05-07 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
TREX WIND-DOWN, INC. Stock Trex Wind-down, Inc.
-83.33% 617
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. TMBRQ Stock